Gomes-Silva, D. et al. CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies. Blood 130, 285–296 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chuntova, P., Downey, K. M., Hegde, B., Almeida, N. D. & Okada, H. Genetically engineered T-cells for malignant glioma: overcoming the barriers to effective immunotherapy. Front. Immunol. 9, 3062 (2018).

Article  CAS  PubMed  Google Scholar 

Ma, L. et al. Enhanced CAR-T cell activity against solid tumors by vaccine boosting through the chimeric receptor. Science 365, 162–168 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lynn, R. C. et al. c-Jun overexpression in CAR T cells induces exhaustion resistance. Nature 576, 293–300 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Adachi, K. et al. IL-7 and CCL19 expression in CAR-T cells improves immune cell infiltration and CAR-T cell survival in the tumor. Nat. Biotechnol. 36, 346–351 (2018).

Article  CAS  PubMed  Google Scholar 

Upadhyay, R. et al. A critical role for Fas-mediated off-target tumor killing in T-cell immunotherapy. Cancer Discov. 11, 599–613 (2021).

Article  CAS  PubMed  Google Scholar 

Hamieh, M. et al. CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape. Nature 568, 112–116 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Martinez, M. & Moon, E. K. CAR T cells for solid tumors: new strategies for finding, infiltrating, and surviving in the tumor microenvironment. Front. Immunol. 10, 128 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bonnardel, J. & Guilliams, M. Developmental control of macrophage function. Curr. Opin. Immunol. 50, 64–74 (2018).

Article  CAS  PubMed  Google Scholar 

Cassetta, L. & Pollard, J. W. Targeting macrophages: therapeutic approaches in cancer. Nat. Rev. Drug Discov. 17, 887–904 (2018).

Article  CAS  PubMed  Google Scholar 

Cortez-Retamozo, V. et al. Origins of tumor-associated macrophages and neutrophils. Proc. Natl Acad. Sci. USA 109, 2491–2496 (2012).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Qian, B. Z. & Pollard, J. W. Macrophage diversity enhances tumor progression and metastasis. Cell 141, 39–51 (2010).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gambardella, V. et al. The role of tumor-associated macrophages in gastric cancer development and their potential as a therapeutic target. Cancer Treat. Rev. 86, 102015 (2020).

Article  CAS  PubMed  Google Scholar 

Chen, Y., Zhang, S., Wang, Q. & Zhang, X. Tumor-recruited M2 macrophages promote gastric and breast cancer metastasis via M2 macrophage-secreted CHI3L1 protein. J. Hematol. Oncol. 10, 36 (2017).

Article  PubMed  PubMed Central  Google Scholar 

DeNardo, D. G. & Ruffell, B. Macrophages as regulators of tumour immunity and immunotherapy. Nat. Rev. Immunol. 19, 369–382 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vitale, I., Manic, G., Coussens, L. M., Kroemer, G. & Galluzzi, L. Macrophages and metabolism in the tumor microenvironment. Cell Metab. 30, 36–50 (2019).

Article  CAS  PubMed  Google Scholar 

Song, M. et al. Tumor derived UBR5 promotes ovarian cancer growth and metastasis through inducing immunosuppressive macrophages. Nat. Commun. 11, 6298 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cioni, B. et al. Androgen receptor signalling in macrophages promotes TREM-1-mediated prostate cancer cell line migration and invasion. Nat. Commun. 11, 4498 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang, R. et al. CCL5 derived from tumor-associated macrophages promotes prostate cancer stem cells and metastasis via activating β-catenin/STAT3 signaling. Cell Death Dis. 11, 234 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Salvagno, C. et al. Therapeutic targeting of macrophages enhances chemotherapy efficacy by unleashing type I interferon response. Nat. Cell Biol. 21, 511–521 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wiehagen, K. R. et al. Combination of CD40 agonism and CSF-1R blockade reconditions tumor-associated macrophages and drives potent antitumor immunity. Cancer Immunol. Res. 5, 1109–1121 (2017).

Article  CAS  PubMed  Google Scholar 

Kang, M. et al. Nanocomplex-mediated in vivo programming to chimeric antigen receptor-M1 macrophages for cancer therapy. Adv. Mater. 33, e2103258 (2021).

Article  PubMed  Google Scholar 

Ries, C. H. et al. Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy. Cancer Cell 25, 846–859 (2014).

Article  CAS  PubMed  Google Scholar 

Akkari, L. et al. Dynamic changes in glioma macrophage populations after radiotherapy reveal CSF-1R inhibition as a strategy to overcome resistance. Sci.Transl. Med. 12, eaaw7843 (2020).

Article  CAS  PubMed  Google Scholar 

Zhang, L. et al. Pluripotent stem cell-derived CAR-macrophage cells with antigen-dependent anti-cancer cell functions. J. Hematol. Oncol. 13, 153 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Klichinsky, M. et al. Human chimeric antigen receptor macrophages for cancer immunotherapy. Nat. Biotechnol. 38, 947–953 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Morrissey, M. A. et al. Chimeric antigen receptors that trigger phagocytosis. eLife 7, e36688 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Takata, K. et al. Induced-pluripotent-stem-cell-derived primitive macrophages provide a platform for modeling tissue-resident macrophage differentiation and function. Immunity 47, 183–198 (2017).

Article  CAS  PubMed  Google Scholar 

Zhang, H. & Reilly, M. P. Human induced pluripotent stem cell-derived macrophages for unraveling human macrophage biology. Arter. Thromb. Vasc. Biol. 37, 2000–2006 (2017).

Article  CAS  Google Scholar 

Lachmann, N. et al. Large-scale hematopoietic differentiation of human induced pluripotent stem cells provides granulocytes or macrophages for cell replacement therapies. Stem Cell Rep. 4, 282–296 (2015).

Article  CAS  Google Scholar 

Kawai, T. & Akira, S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34, 637–650 (2011).

Article  CAS  PubMed  Google Scholar 

Lancaster, G. I. et al. Evidence that TLR4 is not a receptor for saturated fatty acids but mediates lipid-induced inflammation by reprogramming macrophage metabolism. Cell Metab. 27, 1096–1110 (2018).

Article  CAS  PubMed  Google Scholar 

Fan, W. et al. FoxO1 regulates Tlr4 inflammatory pathway signalling in macrophages. EMBO J. 29, 4223–4236 (2010).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fitzgerald, K. A. & Kagan, J. C. Toll-like receptors and the control of immunity. Cell 180, 1044–1066 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kawai, T. & Akira, S. The role of pattern-recognition receptors in innate immunity: update on toll-like receptors. Nat. Immunol. 11, 373–384 (2010).

Article  CAS  PubMed  Google Scholar 

Kondo, T., Kawai, T. & Akira, S. Dissecting negative regulation of toll-like receptor signaling. Trends Immunol. 33, 449–458 (2012).

Article  CAS  PubMed  Google Scholar